Send us a text

Why aren't GLP-1 medications working for everyone?

You may be frustrated that semaglutide or tirzepatide isn't helping you lose weight like it has for others. The problem might not be your diet or willpower - it could be genetic.

Discover how a single gene called TCF7L2 may be sabotaging your weight loss efforts with GLP-1 medications, and what you can do about it.

BY THE TIME YOU FINISH LISTENING, YOU'LL DISCOVER:

• Why 10-15% of people may be "non-responders" to GLP-1 agonists for weight loss
• The gene that could impact the effectiveness of GLP-1
• Strategies to overcome genetic resistance to GLP-1 medications

This episode could be a game-changer if you've been struggling with weight loss despite using GLP-1 agonists.

RESEARCH ARTICLES:

1. Efficacy And Safety Of Semaglutide For Weight Loss In Adults With Overweight Or Obesity
2. A review of receptor interactions and co-stimulation, Peptides
3. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms

Support the show

When you finish listening, I'd love to hear your biggest takeaway from today’s episode. Take a screenshot of you listening on your device, share it to your Instagram stories and tag me, @drtamarlawful!

WANT MORE?
Let's get your health goals in order in a 15 minute Revive and Thrive Session.
Learn How to Safely Use Weight Loss Medications in our Empowerment Hour.
Get a jumpstart on your health with our 10-Day Elite Health Reset.
What could your Genetic Blueprint reveal? Get a sample nutrigenomics report.
Be part of our Community: Join us on Facebook
PRACTITIONERS
Interested in learning how you can help patients focus more on nutrition? Schedule a call here.

FOLLOW US
Facebook/Instagram/LinkedIn/Tiktok: @drtamarlawful
Liked this episode? Share it with a friend.
Love the show? Write a ...